Loading clinical trials...
Loading clinical trials...
An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Intravenously in Patients With Autism
Conditions
Interventions
Fat Harvesting and Stem Cell Injection
Locations
1
United States
Ageless Regenerative Institute LLC
Aventura, Florida, United States
Start Date
October 1, 2016
Primary Completion Date
November 1, 2017
Completion Date
January 1, 2018
Last Updated
July 21, 2017
NCT00271622
NCT06290258
NCT05750095
NCT06329245
NCT05874466
NCT06712784
Lead Sponsor
Ageless Regenerative Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions